title: Topical auranofin ointment for the treatment of plaque psoriasis.
authors.affiliation: Division of Dermatology, Pennsylvania State University College of Medicine, Milton S. Hershey Medical Center, Hershey, USA.
authors.forename: K F
authors.initials: KF
authors.lastname: Helm
authors.forename: J G
authors.initials: JG
authors.lastname: Marks
authors.forename: J J
authors.initials: JJ
authors.lastname: Leyden
authors.forename: C
authors.initials: C
authors.lastname: Guzzo
authors.forename: G G
authors.initials: GG
authors.lastname: Krueger
authors.forename: T W
authors.initials: TW
authors.lastname: Griffiths
authors.forename: C E
authors.initials: CE
authors.lastname: Griffiths
mesh_terms: D000279:Administration, Cutaneous; D001310:Auranofin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D017449:Dermatitis, Allergic Contact / Q000209:etiology; D004311:Double-Blind Method; D004342:Drug Hypersensitivity / Q000209:etiology; D005500:Follow-Up Studies; D006801:Humans; D009824:Ointments; D010577:Petrolatum; D010919:Placebos; D011565:Psoriasis / Q000188:drug therapy*; D012008:Recurrence; D012074:Remission Induction
chemical_list: D009824:Ointments; D010919:Placebos; D001310:Auranofin; D010577:Petrolatum